Issued: March 17 2017 Main contents: With a view to encouraging the simultaneous conduct of foreign and domestic clinical trials, after approval,…
China launches a “Two-Invoice System” to simplify the drug distribution chain and reduce prices and corruption in the healthcare sector. The new policy may bring substantial compliance and business model challenges for pharmaceutical companies